As our data demonstrated that USP14 inhibition reduces NFκB activity and sensitizes cells to TNFα-induced cell death, we assessed whether HNSCC cells could be sensitized to radiation therapy by USP14 inhibition in vitro. Here, NFKB1 is linked to head and neck squamous cell carcinoma.